top of page
FAQs
Frequently asked questions
About entX
Medical Isotopes
Space & Defence
RHU
GenX
Nuclear Technology
entX develops technologies across three key areas:IsoMedica: Developing sovereign medical isotope supply chains for targeted alpha therapy cancer treatments.RHU: Developing radioisotope heating technologies for space and extreme environments.GenX: Developing advanced betavoltaic power systems for long-duration energy applications.
entX works with research organisations, industry partners, investors and government stakeholders interested in advancing nuclear technology applications.Potential partners include:Space organisationsDefence companiesMedical technology companiesResearch institutionsGovernment agenciesResource Companies (Mining and Oil and Gas)Waste Treatment and StorageInvestors.
bottom of page